BIFURCATION ANALYSIS IN A SEROGROUP A MENINGOCOCCAL INFECTION MODEL

被引:1
|
作者
Bah, Alpha Oumar [1 ]
Lam, Mountaga [1 ]
Bah, Alassane [2 ]
Bowong, Samuel [3 ]
机构
[1] Univ Cheikh Anta Diop, Dept Math, Fac Sci & Tech, Dakar, Senegal
[2] Univ Cheikh Anta Diop, Natl Adv Sch Engn, Dept Comp Engn, Dakar, Senegal
[3] Univ Douala, Fac Sci, Dept Math & Comp Sci, Lab Math, POB 24157, Douala, Cameroon
关键词
epidemiological models; serogroup A meningococcal infection; stability; bifurcation; NEISSERIA-MENINGITIDIS; BACKWARD BIFURCATION; SENSITIVITY-ANALYSIS; VACCINATION; DISEASE; EPIDEMIC; TUBERCULOSIS; W135; TRANSMISSION; UNCERTAINTY;
D O I
10.28919/cmbn/3760
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
A mathematical model is formulated that enables the understanding of the dynamics of the transmission of serogroup A meningococcal (MenA) infection. We provide the theoretical analysis of the model. We compute the basic reproduction number R-0 and shows that the outcome of the disease depends on a threshold parameter xi. More precisely, we show that when R-0 <= xi, the disease-free equilibrium is globally asymptotically stable, while when xi <= R-0 <= 1, the model exhibits the phenomenon of backward bifurcation, when a stable diseasefree equilibrium co-exists with one or more stable endemic equilibria. Sensitivity analysis of the model has been performed in order to determine the impact of related parameters on meningitis outbreak. Random perturbation of the vaccine efficacy was performed to gain insight into the role of the vaccine efficacy on the stability of the disease-free equilibrium. Theoretical results are supported by numerical simulations, which further suggest that the control of the epidemic of MenA pass through a combination of a large coverage vaccination of young susceptible individuals and the production of a vaccine with a high level of efficacy.
引用
收藏
页数:38
相关论文
共 50 条
  • [11] Relative stability of meningococcal serogroup A and X polysaccharides
    Berti, F.
    Romano, M. R.
    Micoli, F.
    Pinto, V.
    Cappelletti, E.
    Gavini, M.
    Proietti, D.
    Pluschke, G.
    MacLennan, C. A.
    Costantino, P.
    VACCINE, 2012, 30 (45) : 6409 - 6415
  • [12] Prevention and control of meningococcal outbreaks: The emerging role of serogroup B meningococcal vaccines
    Oviedo-Orta, Ernesto
    Ahmed, Sohail
    Rappuoli, Rino
    Black, Steven
    VACCINE, 2015, 33 (31) : 3628 - 3635
  • [13] Meningococcal Meningitis Outbreaks in the African Meningitis Belt After Meningococcal Serogroup A Conjugate Vaccine Introduction, 2011-2017
    Fernandez, Katya
    Lingani, Clement
    Aderinola, Olaolu Moses
    Goumbi, Kadade
    Bicaba, Brice
    Edea, Zewdu Assefa
    Glele, Clement
    Sarkodie, Badu
    Tamekloe, Agbeko
    Ngomba, Armelle
    Djingarey, Mamoudou
    Bwaka, Ado
    Perea, William
    Ronveaux, Olivier
    JOURNAL OF INFECTIOUS DISEASES, 2019, 220 : S225 - S232
  • [14] Global properties and bifurcation analysis of an HIV-1 infection model with two target cells
    Liu, Yongqi
    Liu, Xuanliang
    COMPUTATIONAL & APPLIED MATHEMATICS, 2018, 37 (03) : 3455 - 3472
  • [15] Meningococcal serogroup Y emergence in Europe Update 2011
    Broeker, Michael
    Jacobsson, Susanne
    Kuusi, Markku
    Pace, David
    Simoes, Maria J.
    Skoczynska, Anna
    Taha, Muhamed-Kheir
    Toropainen, Maija
    Tzanakaki, Georgina
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2012, 8 (12) : 1907 - 1911
  • [16] Differential characteristics of primary infection and re-infection can cause backward bifurcation in HCV transmission dynamics
    Nazari, F.
    Gumel, A. B.
    Elbasha, E. H.
    MATHEMATICAL BIOSCIENCES, 2015, 263 : 51 - 69
  • [17] Mathematical model and backward bifurcation analysis of pneumonia infection with intervention measures
    Teklu, Shewafera Wondimagegnhu
    Kotola, Belela Samuel
    RESEARCH IN MATHEMATICS, 2024, 11 (01):
  • [18] Prevention of serogroup B meningococcal disease
    Stephens, David S.
    LANCET, 2012, 379 (9816) : 592 - 594
  • [19] An effective serogroup B meningococcal vaccine
    Dominguez, Francisco
    Menendez, Jorge
    Ochoa, Rolando
    VACCINE, 2006, 24 (49-50) : 7025 - 7026
  • [20] Trumenba: A Serogroup B Meningococcal Vaccine
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2015, 57 (1459): : 5 - 6